DataArt Joins Biotechnology Association BIO Deutschland
Global technology consultancy DataArt announced today that it has joined BIO Deutschland, Germany's biotechnology industry association.
BIO Deutschland is one of the most influential biotech associations in Europe, established to support and promote the development of an innovative economic sector based on modern biosciences. The Berlin-based association currently has over 285 members and is active in a broad range of events that aim to provide biotechnology with a platform for discussion and interaction.
With an established Life Sciences Practice and dedicated R&D group, DataArt has accumulated extensive knowledge and deep expertise in building cutting-edge technology solutions in drug discovery and clinical trials. DataArt’s clients include prominent life sciences companies, such as Charles River Laboratories, Novaseek Research, PSI CRO, and Cancer Research UK. Within the BIO Deutschland, DataArt’s team has joined the Bio-IT, Big Data & E-Health working group.
“Joining BIO Deutschland is a tremendous opportunity for DataArt, to share our experience, engage with other industry players, and collaborate on resolving challenges,” said Daniel Piekarz, Head of DataArt’s Healthcare and Life Sciences Practice. “We’re particularly excited to join the working group dedicated to Bio-IT, Big Data & E-Health as this is our area of expertise and we look forward to helping move the industry forward.”
This article has been republished from materials provided by DataArt. Note: material may have been edited for length and content. For further information, please contact the cited source.
Cell Technology Used to Treat Osteochondral Knee DefectNews
Autologous cells of stromal vascular fraction were transplanted to a 36-year-old man with the use of fibrin matrix.READ MORE
Compound as Effective as FDA-Approved Drugs Against Life-Threatening InfectionsNews
Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.READ MORE
Chemists Design 'Mini-ecosystems' to Test Drug FunctionNews
Scripps Research scientists have solved a major problem in chemistry and drug development by using droplet-sized 'miniecosystems' to quickly see if a molecule can function as a potential therapeutic.READ MORE